Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible ...

A study conducted by researchers at the Center for Cell-Based Therapy (CTC) highlights key proteins and signaling pathways ...

Explore how cutting-edge agents like alpelisib, capivasertib, MEK and ERK inhibitors, and JAK inhibitors are reshaping the ...

The unfavorable pharmaceutical properties of rapamycin, particularly its poor aqueous solubility and instability, preclude its clinical development as an anti-cancer agent, and, therefore ...

A study conducted by researchers at the Center for Cell-Based Therapy (CTC) highlights key proteins and signaling pathways ...

Envision this possible future clinical scenario: a breast cancer patient and her physicians are deciding on the best possible ...

Positive effects of ART26.12 were observed in a surgical rat model of osteoarthritis, in which either single or repeated oral doses of Artelo’s FABP5 inbitor increased the ability of rats to bear ...

Chronic inflammatory bowel disease is challenging to treat and carries a risk of complications, including the development of bowel cancer. Young people are particularly affected: when genetic ...

Abstract:        Obesity, a growing global issue, has been closely associated with an increased risk of various cancers, especially breast cancer. El ...

In a recent study, researchers have uncovered the biological trigger behind the dangerous immune-related adverse events ...

The trial is expected to generate significant clinical data by late summer 2026. Allarity plans to pursue multiple advantaged ...

Tarpon Springs, Florida Wednesday, June 4, 2025, 12:00 Hrs [IST] ...